Controlling angiogenesis by two unique TGF-β type I receptor signaling pathways

Area of Science:

• Vascular Biology
• Cell Signaling
• Molecular Medicine

Background:

• Transforming growth factor-beta (TGF-β) plays a vital role in vascular development and homeostasis, as evidenced by genetic studies in mice and humans.
• Defects in TGF-β signaling components lead to embryonic lethality in mice due to vascular abnormalities.
• Mutations in TGF-β receptors are associated with vascular disorders such as Hereditary Hemorrhagic Telangiectasia (HHT) and pulmonary arterial hypertension (PAH) in patients.

Purpose of the Study:

• To review the current understanding of the transforming growth factor-beta (TGF-β) signaling pathway.
• To elucidate the regulation of endothelial and vascular smooth muscle cell function by TGF-β.
• To discuss the role of TGF-β in vascular development, homeostasis, and disease.

Main Methods:

• Review of existing genetic studies in mice and human patients.
• Analysis of the direct and indirect effects of TGF-β on endothelial cells.
• Examination of TGF-β's role in the differentiation of mural cell precursors.
• Discussion of proposed TGF-β receptor/Smad pathways (ALK1 and ALK5).

Main Results:

• TGF-β signaling is essential for embryonic vascular development and maintaining vascular homeostasis.
• TGF-β directly influences endothelial cell growth and migration.
• TGF-β is critical for the differentiation of mural precursors into pericytes and smooth muscle cells.
• Defective paracrine TGF-β signaling may cause leaky vessels, a hallmark of HHT.

Conclusions:

• The transforming growth factor-beta (TGF-β) pathway is a key regulator of endothelial and vascular smooth muscle cell function.
• Dysregulation of TGF-β signaling contributes to vascular diseases, including HHT and PAH.
• Understanding TGF-β signaling mechanisms is crucial for developing therapeutic strategies for vascular disorders.